Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian
Jonathan Krakoff(National Institute of Diabetes and Digestive and Kidney Diseases), Robert S. Lindsay(National Institutes of Health), Robert L. Hanson(National Institute of Diabetes and Digestive and Kidney Diseases), William C. Knowler(George Washington University), Sayuko Kobes(National Institutes of Health), Sachiyo Tanaka(Osaka University), Yūji Matsuzawa(Sumitomo Hospital), Tohru Funahashi(The University of Osaka), Coen D.A. Stehouwer(Maastricht University Medical Centre), P. Antonio Tataranni(National Institutes of Health), Casper G. Schalkwijk(Maastricht University)
Cited by 337
Related Papers
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
Circulating Ghrelin Levels Are Decreased in Human Obesity
|Diabetes|2001|2k
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
|Diabetes Care|2007|1.5k
Adiponectin and development of type 2 diabetes in the Pima Indian population
|The Lancet|2002|1.1k